4-butyl-3-(cyclohexylmethyl)-8-(1-(2,6-dimethylbenzoyl)-4-methylpiperidin-4-yl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one

ID: ALA1077779

PubChem CID: 46882916

Max Phase: Preclinical

Molecular Formula: C33H51N3O3

Molecular Weight: 537.79

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2

Standard InChI:  InChI=1S/C33H51N3O3/c1-5-6-15-28-33(39-31(38)36(28)24-27-13-8-7-9-14-27)18-22-35(23-19-33)32(4)16-20-34(21-17-32)30(37)29-25(2)11-10-12-26(29)3/h10-12,27-28H,5-9,13-24H2,1-4H3

Standard InChI Key:  FRWMBAREYKAXIM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    4.7858  -12.8437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3127  -12.1607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5169  -12.3995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4981  -13.2302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2822  -13.5033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0431  -12.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2184  -12.1487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1770  -13.5737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0017  -13.5976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4371  -12.8949    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2595  -12.9201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6508  -13.6475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4719  -13.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9078  -12.9713    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5164  -12.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6892  -12.2174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8606  -11.8996    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8199  -13.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8267  -14.1230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5623  -14.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1068  -15.5243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0739  -13.3477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0568  -12.5207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3383  -12.1226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6297  -12.5459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6443  -13.3718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3674  -13.7743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7324  -12.9973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1671  -12.2961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1222  -13.7243    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9924  -12.3252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4270  -11.6249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0372  -10.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2082  -10.8735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7773  -11.5745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9526  -11.5514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3807  -13.0532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8423  -16.3057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6927  -12.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  1  1  0
  5 19  1  0
  1  8  1  0
 19 20  1  0
  8  9  1  0
 20 21  1  0
  9 10  1  0
 18 22  1  0
 22 23  1  0
 11 12  1  0
  5  1  1  0
  6  7  1  0
  1  2  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  2  3  1  0
 14 28  1  0
  3  4  1  0
 28 29  1  0
 11 16  1  0
 28 30  2  0
 12 13  1  0
 29 31  2  0
 13 14  1  0
 31 32  1  0
 14 15  1  0
 32 33  2  0
 15 16  1  0
 33 34  1  0
 10 11  1  0
 34 35  2  0
 35 29  1  0
  4  5  1  0
 35 36  1  0
  3 17  2  0
 31 37  1  0
  6 10  1  0
 21 38  1  0
  4 18  1  0
 11 39  1  0
M  END

Associated Targets(Human)

CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 537.79Molecular Weight (Monoisotopic): 537.3930AlogP: 6.72#Rotatable Bonds: 7
Polar Surface Area: 53.09Molecular Species: BASEHBA: 4HBD:
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.21CX LogP: 6.17CX LogD: 4.37
Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.39Np Likeness Score: -0.20

References

1. Rotstein DM, Gabriel SD, Makra F, Filonova L, Gleason S, Brotherton-Pleiss C, Setti LQ, Trejo-Martin A, Lee EK, Sankuratri S, Ji C, Derosier A, Dioszegi M, Heilek G, Jekle A, Berry P, Weller P, Mau CI..  (2009)  Spiropiperidine CCR5 antagonists.,  19  (18): [PMID:19674898] [10.1016/j.bmcl.2009.07.122]

Source